ERBB2 and neoplasm: Inhibition of FASN could not only lead to the accumulation of malonyl-CoA, which further represses tumor cells’ FAO and ultimately blocks the cell-cycle, but also impair the correct localization and/or functioning of EGFR and ERBB2 (3, 38).